Objective: Identification and validation of blood-based biomarkers for the diagnosis and
prognosis of mild traumatic brain injury (mTBI) is of critical importance. There have been …

Background The extensive use of computed tomography (CT) after acute head injury is
costly and carries potential iatrogenic risk. This systematic review examined the usefulness …

Background: This study aimed to determine whether glial fibrillary acidic protein (GFAP) is
released after traumatic brain injury (TBI), whether GFAP is related to brain injury severity …

Blood-based biomarkers have been increasingly studied for diagnostic and prognostic
purposes in patients with mild traumatic brain injury (MTBI). Biomarker levels in blood have …

Background and Purpose The brain-specific astroglial protein GFAP is a blood biomarker
candidate indicative of intracerebral hemorrhage in patients with symptoms suspicious of …

Traumatic brain injuries (TBIs) are potentially lethal medical conditions, with symptoms that
can overlap with symptoms of injuries outside the brain. In many cases, current diagnostic …

Background: We investigated the association between serum levels of glial fibrillary acidic
protein (GFAP) and stroke functional outcomes in a cohort of 286 patients with acute …

BACKGROUND Recent studies have suggested that glial fibrillary acidic protein (GFAP)
serum concentrations distinguish between intracerebral hemorrhage (ICH) and ischemic …

Background After traumatic brain injury (TBI), plasma concentration of glial fibrillary acidic
protein (GFAP) correlates with intracranial injury visible on CT scan. Some patients with …

Background: Glial fibrillary acidic protein (GFAP) is an intermediate filament protein found in
the cytoskeleton of astroglia. Recent work has indicated that GFAP may serve as a serum …